The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 31, 2017
Filed:
May. 18, 2006
Applicants:
Philippe Moingeon, Antony, FR;
Laurence Van Overtvelt, Antony, FR;
Alain Razafindratsita, Antony, FR;
Inventors:
Philippe Moingeon, Antony, FR;
Laurence Van Overtvelt, Antony, FR;
Alain Razafindratsita, Antony, FR;
Assignee:
Stallergenes, Antony, FR;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A01N 63/00 (2006.01); A01N 65/00 (2009.01); A61K 39/00 (2006.01); A61K 39/38 (2006.01); A61K 39/02 (2006.01); A61K 39/09 (2006.01); A61K 39/07 (2006.01); A61K 39/35 (2006.01); A61K 39/36 (2006.01); A61K 45/00 (2006.01);
U.S. Cl.
CPC ...
A61K 39/35 (2013.01); A61K 2039/542 (2013.01); A61K 2039/55511 (2013.01); A61K 2039/55594 (2013.01);
Abstract
The invention relates to an immunogenic composition for sublingual, perlingual or oral administration, comprising at least an antigen and at least an adjuvant that is a bacterium selected from aand a lactic acid bacterium, and/or a combination of a corticosteroid with vitamin D3 or any metabolite or analog of the latter, in a pharmaceutically acceptable carrier that is suitable for sublingual, perlingual, or oral administration. Such compositions allow to elicit antigen-specific immune tolerance.